Insider Transactions in Q2 2024 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,645
-13.23%
|
$14,645
$1.39 P/Share
|
|
May 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.29%
|
$2,361
$1.75 P/Share
|
|
May 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.49%
|
$875
$1.75 P/Share
|
|
May 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-0.89%
|
$999
$1.75 P/Share
|
|
May 06
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.44%
|
$834
$1.75 P/Share
|
|
May 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.54%
|
$985
$1.77 P/Share
|
|
May 01
2024
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.48%
|
$917
$1.77 P/Share
|
|
May 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.02%
|
$1,146
$1.77 P/Share
|
|
May 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.34%
|
$2,751
$1.77 P/Share
|